Reports for MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE
Brand name
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE
Company Name
MYLAN PHARMACEUTICALS ULC
|
Drug Identification Number
02461412 |
Ingredients
TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE EFAVIRENZ |
Ingredient Strength
300 MG 200 MG 600 MG |
ATC Code
J05ARJ05AR |
ATC Descriptor
DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS |
Status
MARKETED
|
Shortage reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | 30 BT | Resolved | 2018-04-27 | 2019-06-19 | 47356 |
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | 30 BT | Resolved | 2019-06-25 | 2019-07-03 | 87463 |
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | 30BT | Avoided shortage | 2020-04-29 | 2020-07-09 | 113424 |
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE | 30BT | Actual shortage | 2025-04-14 | 2025-04-14 | 255042 |
Showing 1 to 4 of 4
Discontinuation reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0